About Vivodyne
The Problem Vivodyne addresses a core artificial intelligence pain point: fragmented operations, slow decision cycles, and poor visibility across teams. Organizations in this market often rely on disconnected tools, which creates delays, revenue leakage, and inconsistent customer outcomes.
The Solution Accelerates drug discovery using lab-grown human tissues, robotics, and AI to generate accurate preclinical test data Artificial Intelligence Biotech Healthcare In practice, Vivodyne centralizes critical workflows, automates repetitive coordination, and gives operators a real-time system of record. This reduces manual overhead and improves execution quality at scale.
Why it's growing With the rise of shifting customer expectations, faster digital adoption, and demand for measurable ROI, Vivodyne is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Culture The team operates in a fast-paced environment focused on artificial intelligence innovation, product velocity, and customer-centric execution. Their culture emphasizes ownership, experimentation, and measurable outcomes.
Why it Matters
Vivodyne matters now because with the rise of shifting customer expectations, faster digital adoption, and demand for measurable ROI, Vivodyne is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Funding Snapshot
- Series A • Khosla Ventures, $40M Series A in 2025
Hiring Roles
This company is actively hiring.
Meet the Founders
Vivodyne Team
Founder & CEO